Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Shimoya, K.
Right arrow Articles by Murata, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimoya, K.
Right arrow Articles by Murata, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 9, No. 2, 97-101, February 2003
© 2003 European Society of Human Reproduction and Embryology

Article

Fractalkine (FRK) levels in amniotic fluid and its production during pregnancy

Submitted on March 14, 2002; resubmitted on September 24, 2002. accepted on October 30, 2002

Koichiro Shimoya1,3, Qing Zhang1, Kumiko Tenma1, Yukinobu Ota1, Kazumasa Hashimoto1, Yoshie Shizusawa1, Tadashi Kimura2, Masayasu Koyama1 and Yuji Murata1

1 Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita City, Osaka 565-0871 and 2 Department of Gynecology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan

3 To whom correspondence should be addressed. e-mail: shimoya{at}gyne.med.osaka-u.ac.jp

Fractalkine is a new CX3C chemokine that has chemoattractant activity for T cells, monocytes and natural killer (NK) cells. Western blot analysis revealed that fractalkine protein was detected as a 95 kDa band in both the amniotic fluid and the amnion during the second and third trimesters. Immunohistochemistry using an anti-fractalkine polyclonal antibody revealed positive staining of epithelial cells in amnion and trophoblasts in both the second and third trimesters. Neonatal urine also contained detectable amounts of fractalkine. RT–PCR detected fractalkine mRNA transcripts in the amnion. To determine whether fractalkine receptor (CX3CR1)-positive cells were present in amniotic fluid and amnion, we performed RT–PCR using specific primers for CX3CR1. CX3CR1-positive cells had migrated into the amniotic fluid and the amnion. The present findings suggest that fractalkine found in amniotic fluid may contribute to the immunodefence mechanism during pregnancy.

Key words: amnion/amniotic fluid/CX3CR1/fetal urine/fractalkine


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 IOVSHome page
J.-J. You, C.-H. Yang, J.-S. Huang, M.-S. Chen, and C.-M. Yang
Fractalkine, a CX3C Chemokine, as a Mediator of Ocular Angiogenesis
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5290 - 5298.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
L. Cammas, P. Reinaud, O. Dubois, N. Bordas, G. Germain, and G. Charpigny
Identification of Differentially Regulated Genes During Elongation and Early Implantation in the Ovine Trophoblast Using Complementary DNA Array Screening
Biol Reprod, April 1, 2005; 72(4): 960 - 967.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
Q. Zhang, K. Shimoya, K. Temma, T. Kimura, T. Tsujie, M. Shioji, K. Wasada, O. Fukui, S. Hayashi, T. Kanagawa, et al.
Expression of fractalkine in the Fallopian tube and of CX3CR1 in sperm
Hum. Reprod., February 1, 2004; 19(2): 409 - 414.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.